stars 1 stars 2 stars 3

Apellis has been acquired by Biogen. Please follow along there for the latest news. This page is no longer updated or monitored.

Website https://apellis.com/
Ticker APLS
Revenue $628.8 million
Funding $721.1 million
Employees 522 (384 on RocketReach)
Founded 2008
Address 100 Fifth Ave 3rd Floor, Waltham, Massachusetts 02451, US
Phone +1 502-329-2066
Fax (502) 241-4116
Technologies
Industry Biotechnology Research, Pharmaceuticals, Drug Discovery, Early Stage Drug Development, Healthcare, Drug Delivery, Complement System, Immunology, Peptide Drugs, COPD, Asthma, Ophthalmology, Paroxysmal Nocturnal Hemoglobinuria
Web Rank 2 Million
Keywords Therapeutic Proteins, Protein Therapeutics, Ophthalmology, Ocular Inflammation, Immunology, Rare Diseases, Clinical Trials, Drug Development, Novel Therapies, Biotechnology, Pharmaceutical
Competitors Regeneron, Amgen, RCH NetWorks Inc, Novartis, Bristol Myers Squibb, Biogen, Lilly India, Genentech, AstraZeneca, Vertex Pharmaceuticals +42 more (view full list)
SIC SIC Code 283 Companies, SIC Code 28 Companies
NAICS NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies

Apellis Pharmaceuticals Questions

The Apellis Pharmaceuticals annual revenue was $628.8 million in 2026.

Pascal Deschatelets is the Co-Founder and Chief Scientific Officer of Apellis Pharmaceuticals.

384 people are employed at Apellis Pharmaceuticals.

Apellis Pharmaceuticals is based in Waltham, Massachusetts.

The NAICS codes for Apellis Pharmaceuticals are [32, 325, 32541, 3254].

The SIC codes for Apellis Pharmaceuticals are [283, 28].

Top Apellis Pharmaceuticals Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users